{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:22Z","timestamp":1760244922146},"reference-count":29,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T00:00:00Z","timestamp":1066780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Insulin\u2010like growth factor\u20101 (IGF\u20101) is one of the most critical proteins required for the survival, migration, and growth of melanoma cells. IGF\u2010binding protein 2 (IGFBP2), which binds and regulates the function of IGF\u20101, is upregulated in a dose\u2010dependent manner in melanoma cells treated with IGF\u20101, suggesting a possible role of IGFBP2 in the pathogenesis of melanoma.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Tissue microarrays were constructed using formalin\u2010fixed, paraffin\u2010embedded archival tissue blocks from 94 melanocytic lesions: 20 benign nevi, 20 dysplastic nevi, 23 primary melanomas, and 31 metastatic melanomas. IGFBP2 expression was evaluated immunohistochemically using a polyclonal antibody against the C\u2010terminus of IGFBP2. The number of cells and labeling intensity were assessed semiquantitatively.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Positive IGFBP2 labeling was observed in 5.0% of benign nevi, which was significantly lower than in dysplastic nevi (35.0%), primary melanomas (52.2%), or metastatic melanomas (54.8%) (p\u2003&lt;\u20030.05). Among the IGFBP2\u2010positive cases, moderate\u2010to\u2010strong immunostaining was observed in 64.7% of metastatic melanomas and 33.3% of primary melanomas. But none of the dysplastic nevi had moderate\u2010to\u2010strong immunostaining (p\u2003&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our study shows that IGFBP2 expression increases from benign and dysplastic nevi to primary and metastatic melanomas and suggests that it may play a role in melanoma progression.<\/jats:p>","DOI":"10.1034\/j.1600-0560.2003.00120.x","type":"journal-article","created":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T21:11:23Z","timestamp":1066857083000},"page":"599-605","source":"Crossref","is-referenced-by-count":24,"title":["Expression of insulin\u2010like growth factor\u2010binding protein 2 in melanocytic lesions"],"prefix":"10.1111","volume":"30","author":[{"given":"Huamin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven S.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Hafeez","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory N.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.2741\/A341"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0614"},{"key":"e_1_2_5_4_2","first-page":"7318","article-title":"Insulin\u2010like growth factor\u20101 induces survival and growth of biologically early melanoma cells through both the mitogen\u2010activated protein kinase and beta\u2010catenin pathways","volume":"61","author":"Satyamoorthy K","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199810000-00002"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/08977190009001068"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12477822"},{"key":"e_1_2_5_9_2","first-page":"4848","article-title":"Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin\u2010like growth factor receptor","volume":"54","author":"Resnicoff M","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1472"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.5.1444"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12289713"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03536-G"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000184780"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.12.5944"},{"key":"e_1_2_5_16_2","first-page":"8601","article-title":"Insulin\u2010like growth factor\u2010binding protein 2 in tumorigenesis: protector or promoter?","volume":"61","author":"Hoeflich A","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_5_17_2","first-page":"4228","article-title":"Reactivation of insulin\u2010like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling","volume":"59","author":"Fuller GN","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_5_18_2","first-page":"6617","article-title":"Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques","volume":"60","author":"Sallinen SL","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2000.00700.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.833"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.20.1758"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2000.00200.x"},{"key":"e_1_2_5_23_2","first-page":"293A","article-title":"Overexpression of IGFBP2 in glioblastoma is associated with increased MMP2 expression and tumor invasion","volume":"16","author":"Wang H","year":"2003","journal-title":"Mod Pathol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","unstructured":"ShenSS ZhangPS EtonO PrietoVG.Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array.J Cutan Pathol2003;30:539.","DOI":"10.1034\/j.1600-0560.2003.00090.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2002.tb00426.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780204"},{"key":"e_1_2_5_27_2","first-page":"87","article-title":"Insulin\u2010like growth factor\u2010I\u2010induced migration of melanoma cells is mediated by interleukin\u20108 induction","volume":"13","author":"Satyamoorthy K","year":"2002","journal-title":"Cell Growth Differ"},{"key":"e_1_2_5_28_2","first-page":"3915","article-title":"Reciprocal positive regulation of hypoxia\u2010inducible factor 1alpha and insulin\u2010like growth factor 2","volume":"59","author":"Feldser D","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/28867"},{"key":"e_1_2_5_30_2","first-page":"271","article-title":"Overexpression of insulin\u2010like growth factor binding protein 2 correlates with up\u2010regulation of vascular endothelial growth factor in human diffuse gliomas: an immunohistochemical tissue microarray study of 259 tumors","volume":"3","author":"Wang H","year":"2001","journal-title":"Neuro-oncol"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2003.00120.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0560.2003.00120.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0560.2003.00120.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:14:58Z","timestamp":1697188498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0560.2003.00120.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,22]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1034\/j.1600-0560.2003.00120.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0560.2003.00120.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,22]]}}}